Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Columbia University |
---|---|
Information provided by: | Columbia University |
ClinicalTrials.gov Identifier: | NCT00453713 |
The purpose of this study is to identify factors that contribute to higher mortality rates among blacks and Hispanics with diffuse parenchymal lung disease.
Condition |
---|
Idiopathic Pulmonary Fibrosis Interstitial Lung Disease Diffuse Parenchymal Lung Disease |
Study Type: | Observational |
Study Design: | Cohort, Prospective |
Official Title: | Determinants of Outcome in Diffuse Parenchymal Lung Disease |
Estimated Enrollment: | 400 |
Study Start Date: | February 2007 |
Estimated Study Completion Date: | January 2012 |
It is well known that both socioeconomic and biological factors may contribute to race- and ethnicity-based health disparities. Black and Hispanic Americans have worse access to healthcare services and tend to receive care from physicians who cannot themselves access the same services for their patients that physicians who care for white patients can. These factors may play important roles in the development and maintenance of health disparities. In addition, biological differences may contribute to disparities. We propose to identify factors that explain survival disparities in a group of lung diseases called diffuse parenchymal lung diseases (DPLDs), including a severe form of DPLD called idiopathic pulmonary fibrosis (IPF). We will follow patients with DPLD at our center and measure both social and biological factors to try to identify the factors that lead to survival disparities between races. Results of this study will be used to design clinical trials aimed at reducing these disparities.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Diffuse parenchymal lung disease
Inclusion Criteria:
Exclusion Criteria:
Contact: Nisha A Philip, M.B.B.S. | (212) 305-7720 | np2173@columbia.edu |
United States, New York | |
Columbia University Medical Center | Recruiting |
New York, New York, United States, 10032 | |
Principal Investigator: David J Lederer, M.D. |
Principal Investigator: | David J Lederer, M.D. | Columbia University |
Responsible Party: | Columbia University ( David Lederer ) |
Study ID Numbers: | AAAB8771 |
Study First Received: | March 27, 2007 |
Last Updated: | February 2, 2009 |
ClinicalTrials.gov Identifier: | NCT00453713 History of Changes |
Health Authority: | United States: Institutional Review Board |
Idiopathic pulmonary fibrosis Interstitial lung disease Diffuse parenchymal lung disease Health disparities |
Lung Diseases, Interstitial Respiratory Tract Diseases Fibrosis |
Idiopathic Pulmonary Fibrosis Lung Diseases Pulmonary Fibrosis |
Lung Diseases, Interstitial Pathologic Processes Respiratory Tract Diseases |
Fibrosis Lung Diseases Pulmonary Fibrosis |